Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Peptide Bonds

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Polymer Classification: Architecture

Polymer Classification: Architecture

Polymers are classified as linear or branched on the basis of their chain architecture. The polymer chains in linear polymers have a long chain-like structure with minimal to no branching at all. Even if a polymer features large substituent groups on the monomer, which appear as branches to the skeleton, it is not considered a branched polymer. A branched polymer contains secondary polymer chains that arise from the main polymer chain. The branching occurs when the polymer growth shifts from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Circulating Beta3-Adrenoreceptor as Novel Independent Biomarker for Risk Assessment in Neuroblastoma Patients.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Cooperative Oligomeric Peptide Combinations Enhance the Predicted Therapeutic Profile of SET-M33.

Antibiotics (Basel, Switzerland)·2026

Same author

Marfan Syndrome Prediction Via Graph Neural Networks on 3D Facial Cues.

IEEE journal of biomedical and health informatics·2026

Same author

Reply to the Letter to the Editor by Torsten Christ and Martin C. Michel.

British journal of pharmacology·2026

Same author

Establishment and application of a vesicle extraction method for clinical strains of <i>Pseudomonas aeruginosa</i>.

Microbiology spectrum·2026

Same author

Two Shorter Variants of the Proline-Rich Antimicrobial Peptide B7-005 Scaffold Active Against Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>.

Antibiotics (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Branched peptides as therapeutics.

Alessandro Pini¹, Chiara Falciani, Luisa Bracci

¹Dipartimento di Biologia Molecolare, Università degli Studi di Siena, Via Fiorentina 1, Siena, Italy. pinia@unisi.it

Current Protein & Peptide Science

|October 16, 2008

Summary

Multiple Antigen Peptides (MAPs) show enhanced stability against degradation, making them promising drug candidates. These branched peptides are suitable for various applications, including antimicrobial and anti-tumor therapies.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Published on: August 1, 2018

Related Experiment Videos

Last Updated: Jun 29, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Published on: August 1, 2018

Area of Science:

Biotechnology
Drug Discovery
Immunology

Background:

The 'magic bullet' concept, initially for immunoglobulins, now applies to peptides targeting specific markers.
Peptide drug development faced reluctance due to short half-lives, despite technological advancements.

Purpose of the Study:

To explore the potential of Multiple Antigen Peptides (MAPs) as stable drug candidates.
To evaluate MAPs' resistance to enzymatic degradation for improved drug development.

Main Methods:

Investigated the stability of MAP molecules against proteases and peptidases.
Assessed MAPs for biotechnological applications, including antimicrobial, anti-toxin, and tumor-targeting peptides.

Main Results:

Discovered that MAP molecules exhibit significant resistance to proteases and peptidases.
Demonstrated the suitability of MAPs for various therapeutic applications due to their enhanced stability.

Conclusions:

MAPs offer a stable and versatile platform for peptide drug development.
The inherent stability of MAPs overcomes previous limitations, enabling diverse biotechnological applications.